Population Pharmacokinetics and Exposure–Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms

Daichi Yamaguchi, Yasuhiro Tsuji, Miki Sonoda, Kenji Shin, Hiroko Kito, Chika Ogami, Hidefumi Kasai, Hideto To, Hidetoshi Kamimura

Research output: Contribution to journalArticle

Abstract

Background and Objective: Lithium, which is used to treat bipolar disorder, has a narrow therapeutic blood concentration range and quickly reaches clinically toxic levels. We performed a population pharmacokinetic analysis with a lithium tubular reabsorption model including urinary pH and investigated the relationship between blood lithium concentration and tremor as a side effect. Methods: Routine clinical data, including 389 serum concentrations, were collected from 214 patients orally administered an adjusted amount of lithium carbonate. Pharmacokinetics were described using a one-compartment distribution model with first-order absorption and elimination. The fractions of the MID (Li+ + LiCO3) and ION (2Li+ + CO32−) forms were calculated using the Henderson–Hasselbalch equation, and the influences of these fractions on clearance (CL) were evaluated. The rate of tremor development was analyzed using a logit model. Results: Oral apparent CL (CL/F) was explained by nonrenal CL and renal CL, and renal CL was varied by the fractions of lithium forms influenced by urinary pH. The contribution of MID to CL was slightly larger than that of ION. The rate of tremor development was estimated to be more than 30% when the trough lithium concentration was greater than 1.26 mEq L−1. Conclusion: Renal function and urinary pH are important indices in lithium treatment, so the serum concentration of lithium may be predicted based on the renal function and urinary pH.

Original languageEnglish
Pages (from-to)329-338
Number of pages10
JournalEuropean Journal of Drug Metabolism and Pharmacokinetics
Volume44
Issue number3
DOIs
Publication statusPublished - 2019 Jun 1
Externally publishedYes

Fingerprint

Lithium Carbonate
Lithium
Pharmacokinetics
Population
Tremor
Kidney
Poisons
Serum
Bipolar Disorder
Logistic Models
Therapeutics

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Cite this

Population Pharmacokinetics and Exposure–Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms. / Yamaguchi, Daichi; Tsuji, Yasuhiro; Sonoda, Miki; Shin, Kenji; Kito, Hiroko; Ogami, Chika; Kasai, Hidefumi; To, Hideto; Kamimura, Hidetoshi.

In: European Journal of Drug Metabolism and Pharmacokinetics, Vol. 44, No. 3, 01.06.2019, p. 329-338.

Research output: Contribution to journalArticle

Yamaguchi, Daichi ; Tsuji, Yasuhiro ; Sonoda, Miki ; Shin, Kenji ; Kito, Hiroko ; Ogami, Chika ; Kasai, Hidefumi ; To, Hideto ; Kamimura, Hidetoshi. / Population Pharmacokinetics and Exposure–Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms. In: European Journal of Drug Metabolism and Pharmacokinetics. 2019 ; Vol. 44, No. 3. pp. 329-338.
@article{ffa9746233d940e29c55b5dcf6dc1c08,
title = "Population Pharmacokinetics and Exposure–Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms",
abstract = "Background and Objective: Lithium, which is used to treat bipolar disorder, has a narrow therapeutic blood concentration range and quickly reaches clinically toxic levels. We performed a population pharmacokinetic analysis with a lithium tubular reabsorption model including urinary pH and investigated the relationship between blood lithium concentration and tremor as a side effect. Methods: Routine clinical data, including 389 serum concentrations, were collected from 214 patients orally administered an adjusted amount of lithium carbonate. Pharmacokinetics were described using a one-compartment distribution model with first-order absorption and elimination. The fractions of the MID (Li+ + LiCO3−) and ION (2Li+ + CO32−) forms were calculated using the Henderson–Hasselbalch equation, and the influences of these fractions on clearance (CL) were evaluated. The rate of tremor development was analyzed using a logit model. Results: Oral apparent CL (CL/F) was explained by nonrenal CL and renal CL, and renal CL was varied by the fractions of lithium forms influenced by urinary pH. The contribution of MID to CL was slightly larger than that of ION. The rate of tremor development was estimated to be more than 30{\%} when the trough lithium concentration was greater than 1.26 mEq L−1. Conclusion: Renal function and urinary pH are important indices in lithium treatment, so the serum concentration of lithium may be predicted based on the renal function and urinary pH.",
author = "Daichi Yamaguchi and Yasuhiro Tsuji and Miki Sonoda and Kenji Shin and Hiroko Kito and Chika Ogami and Hidefumi Kasai and Hideto To and Hidetoshi Kamimura",
year = "2019",
month = "6",
day = "1",
doi = "10.1007/s13318-018-0536-0",
language = "English",
volume = "44",
pages = "329--338",
journal = "European Journal of Drug Metabolism and Pharmacokinetics",
issn = "0378-7966",
publisher = "Springer Paris",
number = "3",

}

TY - JOUR

T1 - Population Pharmacokinetics and Exposure–Response of Lithium Carbonate in Patients Based on Tubular Reabsorption Mechanisms

AU - Yamaguchi, Daichi

AU - Tsuji, Yasuhiro

AU - Sonoda, Miki

AU - Shin, Kenji

AU - Kito, Hiroko

AU - Ogami, Chika

AU - Kasai, Hidefumi

AU - To, Hideto

AU - Kamimura, Hidetoshi

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Background and Objective: Lithium, which is used to treat bipolar disorder, has a narrow therapeutic blood concentration range and quickly reaches clinically toxic levels. We performed a population pharmacokinetic analysis with a lithium tubular reabsorption model including urinary pH and investigated the relationship between blood lithium concentration and tremor as a side effect. Methods: Routine clinical data, including 389 serum concentrations, were collected from 214 patients orally administered an adjusted amount of lithium carbonate. Pharmacokinetics were described using a one-compartment distribution model with first-order absorption and elimination. The fractions of the MID (Li+ + LiCO3−) and ION (2Li+ + CO32−) forms were calculated using the Henderson–Hasselbalch equation, and the influences of these fractions on clearance (CL) were evaluated. The rate of tremor development was analyzed using a logit model. Results: Oral apparent CL (CL/F) was explained by nonrenal CL and renal CL, and renal CL was varied by the fractions of lithium forms influenced by urinary pH. The contribution of MID to CL was slightly larger than that of ION. The rate of tremor development was estimated to be more than 30% when the trough lithium concentration was greater than 1.26 mEq L−1. Conclusion: Renal function and urinary pH are important indices in lithium treatment, so the serum concentration of lithium may be predicted based on the renal function and urinary pH.

AB - Background and Objective: Lithium, which is used to treat bipolar disorder, has a narrow therapeutic blood concentration range and quickly reaches clinically toxic levels. We performed a population pharmacokinetic analysis with a lithium tubular reabsorption model including urinary pH and investigated the relationship between blood lithium concentration and tremor as a side effect. Methods: Routine clinical data, including 389 serum concentrations, were collected from 214 patients orally administered an adjusted amount of lithium carbonate. Pharmacokinetics were described using a one-compartment distribution model with first-order absorption and elimination. The fractions of the MID (Li+ + LiCO3−) and ION (2Li+ + CO32−) forms were calculated using the Henderson–Hasselbalch equation, and the influences of these fractions on clearance (CL) were evaluated. The rate of tremor development was analyzed using a logit model. Results: Oral apparent CL (CL/F) was explained by nonrenal CL and renal CL, and renal CL was varied by the fractions of lithium forms influenced by urinary pH. The contribution of MID to CL was slightly larger than that of ION. The rate of tremor development was estimated to be more than 30% when the trough lithium concentration was greater than 1.26 mEq L−1. Conclusion: Renal function and urinary pH are important indices in lithium treatment, so the serum concentration of lithium may be predicted based on the renal function and urinary pH.

UR - http://www.scopus.com/inward/record.url?scp=85058074228&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058074228&partnerID=8YFLogxK

U2 - 10.1007/s13318-018-0536-0

DO - 10.1007/s13318-018-0536-0

M3 - Article

C2 - 30536114

AN - SCOPUS:85058074228

VL - 44

SP - 329

EP - 338

JO - European Journal of Drug Metabolism and Pharmacokinetics

JF - European Journal of Drug Metabolism and Pharmacokinetics

SN - 0378-7966

IS - 3

ER -